how our solutions can address those needs. Develop new business opportunities within the pharma/biopharma and academic markets.... Leverage existing Azenta relationships with pharma/biopharma clients to drive additional bookings. To organize and conduct...
. Catalent is an exciting and growing international company where employees work directly with pharma, biopharma and consumer... to Agency and Search Firm Representatives: Catalent Pharma Solutions (Catalent) is not accepting unsolicited resumes...
of transitioning to a Therapeutic Sales Specialist role at LEO Pharma. Role & Responsibilities: Establishes and builds... Additional duties as assigned by LEO Pharma Management Key Working Relationships: External: Healthcare practitioners/office...
The BBC hears the owner of the luxury store scoped out his victims on the shop floor, assaulted them in London, Paris and St Tropez, and pressured them to keep quiet. Continue Reading »
Sebi initiated action into Axis Capital after publication of a report titled ‘Is Axis Capital an Investment Bank or a Hedge Fund?’ authored by a research analyst. Continue Reading »
Experts rule out a runaway rally, given the steep valuations across large swathes of the market, expecting large caps to outperform broader markets. Continue Reading »
As of 10 a.m. Eastern time, the Dow Jones was up 1.2 per cent, the Nasdaq Composite was 2.2 per cent higher, and the S&P 500 was 1.5 per cent higher Continue Reading »
While foreign investors remain wary due to high valuations, Wood believes India’s domestic fundamentals will help cushion its markets from global volatility. Continue Reading »
The Indian stock market has gained significantly this year, with the Sensex up 15% and Nifty 50 up 17%. Experts recommend quality stocks for long-term gains amid optimism and caution. Top picks include Persistent Systems and HDFC Life. Continue Reading »
Earlier this month, global brokerage firm Goldman Sachs downgraded Indus Towers from a 'Neutral' rating to 'Sell,' lowering the target price to ₹220. Continue Reading »
Centrum Broking has initiated coverage on the wealth management sector, issuing a REDUCE rating for 360 One WAM and Nuvama Wealth. Target prices are ₹1,050 and ₹7,180, respectively, reflecting downsides for both amid a growing market for wealth management in India. Continue Reading »